Cancer Clinical Trials Results
|07-267|| ||Collection of Blood and Tissue from Patients with Upper Aerodigestive Malignancies for Research Purposes (The UAM Tissue Resource)||Main Campus|| || ||Esophageal, Head & Neck, Lung, Mesothelioma, Thyroid
|CALGB 30901||12-645||Randomized Phase II Study of Maintenance Pemetrexed versus observation for patients with malignant pleural mesothelioma without progression after first-line chemotherapy||Beachwood, Fairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Parma, Strongsville, Wooster|| ||Phase 2||Mesothelioma
|VERA 1513||13-885||A Phase II Randomized Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 in subjects with malignant pleural mesothelioma (Verastem, Inc)||Main Campus|| ||Phase 2||Pleural Mesothelioma
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2014 Cleveland Clinic. All rights reserved.